Zanini M - Search Results

1

Dose-escalation of CHOP in non-Hodgkin's lymphoma.

Santoro A, Balzarotti M, Tondini C, Zanini M, Giardini R, Latteri F, Rampinelli I, Bufalino R. Santoro A, et al. Among authors: zanini m. Ann Oncol. 1999 May;10(5):519-25. doi: 10.1023/a:1026422224980. Ann Oncol. 1999. PMID: 10416000 Free article.

2

Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas.

Tondini C, Zanini M, Lombardi F, Bengala C, Rocca A, Giardini R, Buzzoni R, Valagussa P, Bonadonna G. Tondini C, et al. Among authors: zanini m. J Clin Oncol. 1993 Apr;11(4):720-5. doi: 10.1200/JCO.1993.11.4.720. J Clin Oncol. 1993. PMID: 8478665

3

Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.

Bonfante V, Santoro A, Viviani S, Devizzi L, Balzarotti M, Soncini F, Zanini M, Valagussa P, Bonadonna G. Bonfante V, et al. Among authors: zanini m. J Clin Oncol. 1997 Feb;15(2):528-34. doi: 10.1200/JCO.1997.15.2.528. J Clin Oncol. 1997. PMID: 9053474

4

Initial chemotherapy for primary resectable large-cell lymphoma of the stomach.

Tondini C, Balzarotti M, Santoro A, Zanini M, Fornier M, Giardini R, Di Felice G, Bozzetti F, Bonadonna G. Tondini C, et al. Among authors: zanini m. Ann Oncol. 1997 May;8(5):497-9. doi: 10.1023/a:1008206329583. Ann Oncol. 1997. PMID: 9233531 Free article.

5

Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.

Viviani S, Bonadonna G, Santoro A, Zanini M, Zucali R, Negretti E, Valagussa P. Viviani S, et al. Among authors: zanini m. Ann Oncol. 1991 Feb;2 Suppl 2:55-62. doi: 10.1007/978-1-4899-7305-4_9. Ann Oncol. 1991. PMID: 1710921 Free article. Clinical Trial.

6

Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.

Viviani S, Bonadonna G, Santoro A, Bonfante V, Zanini M, Devizzi L, Soncini F, Valagussa P. Viviani S, et al. Among authors: zanini m. J Clin Oncol. 1996 May;14(5):1421-30. doi: 10.1200/JCO.1996.14.5.1421. J Clin Oncol. 1996. PMID: 8622055 Clinical Trial.

7

Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's disease.

Bonfante V, Viviani S, Santoro A, Devizzi L, Di Russo A, Zanini M, Soncini F, Soto Parra H, Valagussa P, Bonadonna G. Bonfante V, et al. Among authors: zanini m. Br J Haematol. 1998 Nov;103(2):533-5. doi: 10.1046/j.1365-2141.1998.00989.x. Br J Haematol. 1998. PMID: 9827930 Free article. Clinical Trial.

8

Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.

Viviani S, Bonfante V, Santoro A, Zanini M, Devizzi L, Di Russo AD, Soncini F, Villani F, Ragni G, Valagussa P, Bonadonna G. Viviani S, et al. Among authors: zanini m. Cancer J Sci Am. 1999 Sep-Oct;5(5):275-82. Cancer J Sci Am. 1999. PMID: 10526668 Clinical Trial.

9

Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP.

Bonfante V, Santoro A, Viviani S, Zucali R, Devizzi L, Zanini M, Tesoro Tess JD, Valagussa P, Banfi A, Bonadonna G. Bonfante V, et al. Among authors: zanini m. Eur J Cancer. 1992;29A(1):24-9. doi: 10.1016/0959-8049(93)90570-6. Eur J Cancer. 1992. PMID: 1445741

10

Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).

Zanini M, Viviani S, Santoro A, Soncini F, Bonfante V, Devizzi L, Villani F, Castellani MR, Negretti E, Zucali R, et al. Zanini M, et al. Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):813-9. doi: 10.1016/0360-3016(94)90354-9. Int J Radiat Oncol Biol Phys. 1994. PMID: 7525516 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters